Clinuvel Pharmaceuticals Limited's total assets for Q4 2024 were AU$231.12M, an increase of 9.18% from the previous quarter. AU:CUV total liabilities were AU$28.11M for the fiscal quarter, a -14.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.